Medicare Advantage beneficiaries used what amounted to $8,718 less in resources than traditional Medicare beneficiaries within six months of beginning chemotherapy treatment, according to a study published Sept. 20 in JAMA Network Open.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
